More bang for your buck: second medical use and the EPC 2000
Second and further medical use claims provide companies and patent lawyers with interesting opportunities, as Caroline Pallard explains.
Personalised medicine in Europe: is the patent system keeping up?
The rise of so-called personalised medicine presents new challenges and opportunities for drugs companies, says Robert Andrews.
Tackling the patent backlog in Brazil
It’s been a long time coming, but perhaps the Brazilian patent office is finally going to deal with the logjam of patent applications, says Gabriel di Blasi.
Aiming high: Canadian biotech
In a global league, Canada’s biotech industry would be respectably mid table. LSIPR talks to Andrew Casey, president of industry association BIOTECanada, about how the organisation is trying to take it to the next level.
Hive mentality: using open source research to develop diagnostic solutions
Susana Soares is a designer inspired by scientific research to create objects that explore new aesthetic and behavioural opportunities. LSIPR investigated how she protects her work in a realm where life sciences and design collide.
Cellular Dynamics: cells to order
Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field.
SPCs at the CJEU
Three December decisions from the Court Of Justice of the European Union shed light on supplementary protection certificates in Europe.
Number crunching: the search for potential therapies
How can ‘big’ data help drug candidates through the pipeline? And who does the data belong to? LSIPR spoke to NuMedii chief executive Gini Deshpande.
Big in Japan: Riken and patents
As the largest science research institute in Japan, Riken has an important role in promoting innovation. LSIPR talked to Akihiro Fujita, director of the institute’s research cluster for innovation, about the place of intellectual property in that endeavour.
Patenting diagnostic methods post-Myriad
The first US court decision applying the Myriad decision has landed, and it makes for interesting reading, as Antoinette Konski reports.
